tirzepatide surmount 5 SURMOUNT-5 (NCT05822830) was a multi-center, randomized, open-label, phase 3b trial evaluating the efficacy and safety of #Zepbound® (tirzepatide) compared with #Wegovy® (semaglutide, similar to full dose #ozempic) in adults with obesity + Lilly Shows Tirzepatide Superiority in
Pay in 4 interest-free payments of $6.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29




















:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)







